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What is the function of MrpL32 and do all of its activi-
ties require m-AAA proteolysis? Nolden et al. (2005)
show that mitochondrial translation is diminished to a
similar extent in the absence of either MrpL32 or a
functional m-AAA protease. This indicates that the
m-AAA protease is likely to control mitochondrial trans-
lation through processing of MrpL32 (Nolden et al.,
2005), although this conclusion was not formally dem-
onstrated. The reason for the drastic impact on mito-
chondrial translation is unclear. Processing of MrpL32
by the m-AAA protease results in a very tight associa-
tion of MrpL32 with the mitochondrial inner membrane,
even though no transmembrane domains are predicted.
The association of MrpL32 with the inner membrane
might serve to localize active ribosomes to the mem-
brane, which may be important for efficient translation.
Not all of the functions of MrpL32 require that it be pro-
cessed given that large ribosomes still assemble with-
out unprocessed MrpL32, in mitochondria with de-
fective m-AAA protease. In contrast, in the absence of
MrpL32, ribosomes, both large and small, fail to assem-
ble. This implies that the incorporation of mature
MrpL32 into the large ribosome is critical for translation
in mitochondria. Alternatively, processed MrpL32 may
exist in a complex independent of the large ribosome
but still essential for mitochondrial translation. This lat-
ter possibility is supported by the observation that pro-
cessed MrpL32 only partially comigrates with large ri-
bosomal subunits in sucrose gradients.
Finally, Nolden et al. (2005) demonstrate the conser-
vation of MrpL32 processing by showing that the
mousem-AAA protease can process yeast MrpL32 and
vice versa. Moreover, in liver mitochondria from mouse
cells lacking paraplegin, an apparently unprocessed
form of MrpL32 accumulates, although processed
MrpL32 is readily detected. The fact that there is some
processing of MrpL32 in mitochondria lacking para-
plegin clearly indicates that in both mice and humans,
there may exist unidentified AAA-protease subunits
that can pair with Afg3L2 and partially replace para-
plegin or other unrelated proteases, absent in yeast,
compensating for loss of paraplegin. Strikingly, the in-
complete processing of mouse MrpL32 in mitochondria
lacking paraplegin correlates with a decrease in mito-
chondrial translation. However, it must be pointed out
that a similar experiment using muscle biopsies ob-
tained from HSP patients harboring a deleted para-
plegin gene failed to reveal any defect in mitochondrial
translation (Atorino et al., 2003).
In the end, the lack of processing of MrpL32 by
m-AAA protease may not be the critical event that
causes the pathology of HSP. Instead, what the work
reported by Nolden et al. (2005) reveals is the possibility
of a more general pathogenic mechanism involving the
absence of proteolytic activation of additional sub-
strates of the m-AAA protease, which may account for
HSP. This mechanism does not mutually exclude the
involvement of an accumulation of nonassembled pro-
teins in the mitochondrial inner membrane. In fact, one
could argue that such proteins may act to clog com-
pensatory proteases, effectively competing with sub-
strates that require proteolysis for their activity. The
critical question that still remains is why is it specifically
the neurons with the longest axons that are affected by
the mutation of a mitochondrial protein with an appar-
ent housekeeping function? The revelation by Nolden
et al. (2005) of a new mechanism for HSP associated
with a defect in paraplegin should aid in the resolution
of this fundamental question.
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ADAM and Eph: How Ephrin-
Signaling Cells
Become Detached
Ephrin ligands presented on one cell surface associ-
ate with their receptors on the surface of a juxtaposed
cell, often resulting in cell-cell repulsion. In this issue
of Cell, Janes et al. (2005) show that the ephrin ligand
can be proteolytically released from its membrane
tether by a complex on the opposing cell composed
of the ephrin receptor and an ADAM metalloprotease.
Ephrins are plasma membrane bound proteins that
function as signaling ligands for a large family of recep-
tor tyrosine kinases, the Eph receptors. Ephrin signal-
ing guides cell migration and determines the path of
cellular protrusions by influencing cell adhesion and
organization of the cytoskeleton. Ephrin signaling has
been well characterized in the nervous system where it
has been shown to guide growing neuronal processes
to their targets. For example, in the visual system,
ephrin gradients regulate the spatial mapping of retinal
Cell
186ganglion cells to higher brain centers (Brown et al.,
2000). However, ephrins have also been implicated in
functions outside the nervous system, for example, in
cell morphogenesis, tissue patterning, and angiogen-
esis (for a review on ephrin receptor signaling, see
Pasquale, 2005).
Ephrins are characterized by an N-terminal extracel-
lular receptor binding domain that adopts a globular
β-barrel structure with “Greek-key” folding topology.
Attachment of this domain to the membrane is pre-
ceded by a linker region ofw40 amino acids. There are
two subfamilies of ephrins: the A subclass, which is GPI
anchored to the cell surface, and the B subclass, which
is anchored by a single transmembrane segment fol-
lowed by a short conserved cytoplasmic region ending
with a PDZ binding motif (reviewed in Barton et al.,
2004). The human genome encodes six ephrin-A and
three ephrin-B ligands.
Vertebrates express ten ephrin-A and six ephrin-B
receptors, which show a high degree of conservation
within each class. Extracellular regions of these recep-
tors have a conserved architecture consisting of an
N-terminal ligand binding domain with a “β-jelly roll”
fold, a cysteine-rich region containing an EGF-like mo-
tif, and two fibronectin type III repeats (see Figure 1).
The cytoplasmic organization of these single-pass
transmembrane proteins is also conserved and con-
sists of a tyrosine kinase domain and a C-terminal ster-
ile αmotif (SAM), a small domain thought to be involved
in protein-protein interactions (Barton et al., 2004). Fur-
thermore, a multitude of receptor variants may be pro-
duced by alternative splicing.
With a few exceptions, receptor-ligand interactions
are class restricted (reviewed in Kullander and Klein,
2002). Thus, ephrin-A ligands activate EphA receptors,
and likewise for the B subclass. However, within each
subclass, ligand-receptor interactions are promiscu-
ous, although binding affinities can vary substantially
for different ligand/receptor pairs. Nonetheless, cog-
nate ephrin/receptor complexes typically form with
nanomolar affinity. Furthermore, after the initial binding
event, ligand/receptor pairs oligomerize to form large
signaling aggregates (Barton et al., 2004). This poses a
paradox: The tight binding of a membrane bound re-
ceptor to a ligand tethered to an opposing cell would
be expected to favor adhesion, so how can this be rec-
onciled with the typically repulsive activity of the
ephrins? A solution to this paradox began to emerge a
few years ago when Flanagan and colleagues elegantly
showed that ephrin-A2 forms a stable complex with the
metalloprotease Kuzbanian (KUZ), the Drosophila ho-
molog of ADAM10 (Hattori et al., 2000).
ADAM (a disintegrin and metalloprotease) proteins
are membrane-anchored metalloproteases that medi-
ate a wide variety of specific proteolytic events at the
cell surface (reviewed in Blobel, 2005). For example,
ADAMs catalyze the regulated ectodomain shedding of
TGF-α, TNF-α, and the notch ligand Delta, a process
that is critical to their signaling function. Furthermore,
in Drosophila, KUZ/ADAM10 is required for the normal
extension of axons (Fambrough et al., 1996).
The large family of ADAM proteases has a character-
istic domain organization. The extracellular region of
the mature protein is comprised of an N-terminal metal-
F
E
D
o
e
i
p
b
A
t
t
c
l
c
u
a
t
s
i
n
i
p
t
c
m
p
s
f
figure 1. The Association between the ADAM10 Protease and the
phrin-A5/EphA3 Ligand-Receptor Signaling Complex
epicted is the plasma membrane (yellow) of two juxtaposed cells,
ne presenting the ephrin ligand, and the other presenting the
phrin receptor in constitutive association with the protease. Bind-
ng of the ephrin ligand to the receptor-protease complex activates
roteolysis (red arrow) to remove the ephrin ligand from its mem-
rane tether. Interactions between the cysteine-rich domain of
DAM10 and the receptor-ligand pair appear to confer a specificity
hat may result in activation of the protease. Subsequently, the en-
ire complex (light blue box) can be taken up by endocytosis by the
ell expressing the receptor.oprotease domain, a disintegrin domain followed by a
ysteine-rich region, and an EGF-like domain (see Fig-
re 1). A single-pass transmembrane segment leads to
cytoplasmic domain that often contains signaling mo-
ifs such as proline-rich regions and phosphorylation
ites. Interestingly, although ADAMs exhibit specificity
n the choice of their substrates, this specificity does
ot appear to reside in the proteolytic domain, which
s able to cleave polypeptide chains without obvious
reference for primary sequence (Blobel, 2005).
Flanagan and colleagues showed that, upon forma-
ion of the ephrin-A2/EphA3 signaling complex, KUZ
atalyzed the proteolytic shedding of ephrin-A2 from its
embrane tether. Furthermore, cultured neurons ex-
ressing a mutant ephrin-A2, which is competent for
ignaling but that cannot be proteolytically cleaved,
ailed to exhibit normal repulsive axon withdrawal ef-
ects (Hattori et al., 2000). It is likely that the defect in
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187this withdrawal function is due, at least in part, to an
impairment of axon detachment.
In the current issue of Cell, Janes et al. (2005) shed
new light on the mechanism by which ADAM10 in-
teracts with an ephrin-signaling complex and reveal an
unexpected twist. These authors present a detailed
functional mutagenesis study of ADAM10, with read-
outs for the binding, cleavage, and internalization of the
ephrin-A5/EphA3 complex. Their work is also enriched
by crystallographic analysis of the ADAM10 disintegrin
and cysteine-rich domains.
Janes et al. (2005) show, surprisingly, that ADAM10
constitutively associates with the ephrin binding do-
main of the EphA3 receptor, and this association is en-
hanced by the presence of the ephrin-A5 ligand. This
contrasts, without necessarily contradicting, the prior
work on KUZ, the Drosophila homolog of ADAM10. KUZ
was shown by coimmunoprecipitation experiments to as-
sociate with the ephrin-A2 ligand, rather than its EphA3
receptor. Interestingly, fragments of ADAM10 bind to
ephrin-A2 and -A1 but not to ephrin-A5. Nonetheless,
for both ephrin-A2 and ephrin-A5, complex formation
with the EphA3 receptor is required for ephrin cleavage.
Furthermore, the current work reports functional dis-
section of the interaction between ADAM10 and EphA3,
revealing that the ligand binding domain of the EphA3
receptor is responsible for binding to ADAM10. Whereas
ADAM10 constitutively associates with EphA3, a high-
affinity binding site within the cysteine-rich domain of
ADAM10 binds to the ephrin-A5/EphA3 complex but to
neither component alone. This suggests the potential
basis for a conformational “switch” activated only upon
complex formation, providing a possible structural ba-
sis for the regulation of proteolysis. This model also
provides an explanation for the selectivity of cleavage
by ADAM despite the lack of primary sequence speci-
ficity observed for the protease domain alone.
The crystal structure of the cysteine-rich domain and
disintegrin domain fragment from ADAM10, also pre-
sented in the report by Janes et al. (2005), reveals an
acidic surface pocket in the cysteine-rich domain that
could serve as a binding site for the ephrin/Eph com-
plex. Disruption of the acidic character of this pocket
by site-directed mutagenesis greatly diminishes bind-
ing to the complex, whereas the constitutive associa-
tion with the EphA3 receptor alone remains unper-
turbed, suggesting a second site of interaction.
A key finding of the current report is that ADAM10
cleaves ephrin-A5 from its membrane tether only in
trans. Thus, consistent with its constitutive association
with the EphA3 receptor, ADAM10 must be presented
by the juxtaposed cell. This is in contrast to other char-
acterized ADAM-mediated proteolytic events, which so
far have been shown only to occur in cis, that is, when
both enzyme and substrate are expressed within the
same cell (Blobel, 2005). Thus, for ephrin-A5/EphA3,
both initiation and termination of ephrin signaling pro-
ceed as intercellular events, dependent on the apposi-
tion of the cells expressing ligand and receptor. Al-
though proposed previously (Blobel, 1997), ADAM10
appears to be the first example of a protease that
cleaves its substrate in a manner that is cell nonauton-
omous.
In the ephrin system, the cell harboring the EphA3receptor has the machinery to both initiate (via the re-
ceptor) and terminate (via the protease) the signal. Pro-
teolysis in trans ensures that cleavage of the ephrin will
occur only upon binding to its receptor on another cell.
The proteolytic event that detaches ephrin-A5 from its
membrane tether releases the adhesive bond between
the two cells, allowing the cells to move apart. Further-
more, the postcleavage ephrin-A5/EphA3 complex is
then endocytosed by the cell expressing the receptor.
Given this example of ADAM-mediated proteolysis
between cells that are attached through the interaction
of ephrin-A5 and the EphA3 receptor, the questions
arise: How general is this mechanism? Do other ephrin/
receptor pairs share the same fate? Do other ADAM
proteases act on other ephrin pairs? Finally, as ADAM
proteases appear to have many specific substrates de-
spite the apparent lack of specificity in their protease
domains, might these other ADAMs use a similar sub-
strate recognition and activation mechanism involving
the cysteine-rich domain as Janes et al. propose? It
remains to be understood, for example, how the prote-
ase exerts its function in the context of oligomerized
signaling pairs at the intercellular interface. Future in-
vestigations may begin to answer these questions and
may also provide insight into the apparent requirement
for higher-order clustering of signaling components.
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